Lin, Su
Fujian Medical University,
China
2025 Rank: 221162
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2124 out of 108265 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 221162 | 246879 |
| Total Cites | 499 | 518 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 113 | 118 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 261 | 266 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 458 | 474 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.09 |
| Self-Citation Percentage |
3.67%
|
|
Lin, Su
Fujian Medical University,
China
2024 Rank: 191357
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Virology
Rank in SubField 1: 1977 out of 103730 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 191357 | 221468 |
| Total Cites | 513 | 528 |
| H-index | 10 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 122 | 123 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 325 | 330 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 477 | 488 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.08 |
| Self-Citation Percentage |
2.84%
|
|
Lin, Su
Fujian Medical University,
China
2023 Rank: 180976
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1901 out of 98720 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 180976 | 202144 |
| Total Cites | 574 | 596 |
| H-index | 11 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 130 | 137 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 356 | 367 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 541 | 554 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.08 |
| Self-Citation Percentage |
3.69%
|
|
Lin, Su
Fujian Medical University,
China
2022 Rank: 153786
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1694 out of 95371 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 153786 | 174919 |
| Total Cites | 730 | 757 |
| H-index | 11 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 110 | 116 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 449 | 461 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 696 | 704 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.08 |
| Self-Citation Percentage |
3.57%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.